United States · 
Who invested in Synereca Pharmaceuticals?
Synereca Pharmaceuticals's investors include i2E, Accele Venture Partners, Accele Biopharma and Oklahoma Seed Capital Fund.
20112012201320142015
$340KVenture$1.4MDebt$600KVentureUnited States · Venture startup
Who invested in Synereca Pharmaceuticals
Funding summaryUpdated 26 Oct 2026
$2.3Mraised across 3 rounds since 2011, from 3 sources
$340KVenture$1.4MDebt$600KVenture
- Latest round
- Venture, $600KAug 2015
- Biggest round
- $1.4MDebt · Sept 2014
- Investors
- 4
The funding story
Each circle is a round, placed by date and sized by amount. The line above is the running total.
- First round
- Venture, $340K Feb 2011
- Biggest round
- $1.4M Debt · Sept 2014
- Usual gap between rounds
- 3.6 years the median of 2
The rounds
- Aug 2015Venture$600K1 new3 returning
From a historical funding record
- Sept 2014
- Feb 2011Venture$340K
No investor was named in the report.
Reported by sec.govSEC filing: $300K sold, first sale Dec 2010
Founders and team
From the SEC filings it signed: 2 on the team.
- Clayton I. DuncanExecutive Officer, Directori
- Richard E. GammansExecutive Officer, Promoteri
On the board, as filediBennett W. LoveMark I. CorriganScott F. SingletonScott I. Meacham
Who was in which round
The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.
Everyone who backed them
Accele Venture PartnersVC firm2rounds
Accele BiopharmaInvestment firm2rounds
Oklahoma Seed Capital FundVC firm1round
Missing a round, or an investor who was in one? Tell us.
Quick answers about Synereca Pharmaceuticals
How much has Synereca Pharmaceuticals raised?
Synereca Pharmaceuticals has raised $2.3M across 3 rounds since 2011.
When did Synereca Pharmaceuticals last raise?
Synereca Pharmaceuticals's most recent round was a Venture of $600K in Aug 2015.
What was Synereca Pharmaceuticals's biggest round?
Synereca Pharmaceuticals's largest round on record is $1.4M (Debt), in Sept 2014.
Who backed Synereca Pharmaceuticals first?
Synereca Pharmaceuticals's first round on record, in Sept 2014, was backed by i2E, Accele Venture Partners and Accele Biopharma.
What stage is Synereca Pharmaceuticals at?
Synereca Pharmaceuticals's latest named round is a Venture, in Aug 2015.
Where is Synereca Pharmaceuticals based?
Synereca Pharmaceuticals is based in the United States.
Companies like Synereca Pharmaceuticals
In the same sector, and raised in the last eighteen months.
Find investors like these
Search every investor by what they have actually funded, then narrow to your stage and market. Free.